NCT05444491View on ClinicalTrials.gov

Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Colorectal Cancer
Trial Locations (7)

100029

Cancer hospital Chinese academy of medical sciences, Beijing

Unknown

West China Hospital, Chengdu

Sun Yat-sen University Cancer Center, Guangzhou

The Second Affiliated Hospital of Harbin Medical University, Haerbin

The First Affiliated Hospital of Naval Medical University/ Changhai Hospital, Shanghai

Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen

Shanxi Cancer hospital (Shanxi Cancer institute), Taiyuan

All Listed Sponsors
collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

lead

Singlera Genomics Inc.

INDUSTRY